GP PHARM, S.A.
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 17, 2017 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 112 Total Citation Count
- Jul 21, 1994 Earliest Filing
- 7 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9789064 Method for delivering a peptide to a subject at a modulated rate via microcapsules of lactic-co-glycolic copolymer containing said peptideApr 23, 08Oct 17, 17[A61K]
5736161 Pharmaceutical preparation for improving the bioavailability of drugs which are difficult to absorb and a procedure for obtaining itJul 21, 94Apr 07, 98[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0130,446 INJECTABLE TAXANE PHARMACEUTICAL COMPOSITIONAbandonedAug 06, 09Jun 02, 11[A61J, A61K, A61P]
2011/0124,563 PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF SOMATOSTATIN OR AN ANALOGUE THEREOFAbandonedNov 21, 08May 26, 11[A61K, A61P]
2009/0196,920 PHARMACEUTICAL COMPOSITION COMPRISING MICROCAPSULES OF STATINS SUSPENDED IN ALKYL ESTERS OF POLYUNSATURATED FATTY ACIDS (PUFA)AbandonedOct 13, 05Aug 06, 09[A61K]
7153490 Liposomes encapsulating anticancer drugs and use thereof in the treatment of malignant tumorsExpiredOct 03, 01Dec 26, 06[A61K]
2005/0123,618 Method of producing micro-capsules for the sustained release of drugsAbandonedJan 25, 05Jun 09, 05[A61K]
6521599 Stable pharmaceutical formulation for intravenous or intramuscular administration of active peptide compoundsExpiredOct 10, 01Feb 18, 03[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.